The PILLS Act creates tax credits to encourage domestic production of generic drugs and biosimilars in the United States. It offers a production credit of 30% (increasing to 35% for final drug production) with an additional bonus for components made with U.S. materials, phasing out after 2033. The bill also provides a separate 25% investment credit for facilities building or expanding production of these drugs, ending for construction after December 31, 2028. To qualify, manufacturers must produce drugs in the U.S., meet FDA compliance requirements, and not be foreign entities of concern. These provisions primarily affect U.S.-based pharmaceutical companies producing generic drugs and biosimilars.
S 2575, the Healthcare for Our Troops Act, eliminates individual premiums for members of the Selected Reserve in the Armed Forces under the TRICARE Reserve Select military health plan. It establishes a uniform 28% monthly premium for family coverage (based on actuarial costs), replaces enrollment fees, and requires the Department of Defense to develop new forms for civilian providers to track reserve members' medical readiness and deployment fitness. The bill directly affects Selected Reserve service members and their immediate families, with changes taking effect one year after enactment. These provisions aim to reduce out-of-pocket costs for reserve members while standardizing family coverage costs.
HRES 1002 is a symbolic House resolution recognizing the Older Americans Act (OAA) nutrition program, which provides meals and social services to seniors aged 60+. It directly affects millions of older adults - particularly those who are homebound, isolated, or facing hunger, malnutrition, or chronic health conditions - by highlighting how the program reduces hospital visits, lowers healthcare costs, and improves quality of life. Key provisions include acknowledging the program’s role in preventing falls and institutionalization, emphasizing volunteer support as its "backbone," and urging Congress to secure sustained federal funding. As a non-binding resolution, it does not change policy but formally endorses the program’s value and calls for community and legislative support.
HRES 835 is a symbolic resolution declaring gun violence a public health crisis in the United States. It urges federal agencies, particularly the Centers for Disease Control and Prevention (CDC), to apply a public health framework - including data collection, prevention research, and coordinated government action - to address gun violence. The resolution supports similar declarations already made by states and cities, and calls for the Surgeon General to issue a report on firearm violence prevention. As a non-binding resolution, it does not create new laws or allocate funding but aims to shift the national approach to gun violence as a preventable health issue.
The Home-Based Telemental Health Care Act of 2025 would authorize federal grants to expand mental health and substance use services for rural underserved populations and workers in farming, fishing, or forestry occupations. Grant recipients must deliver care via telehealth directly in patients' homes or comfortable settings, measure its effectiveness compared to in-person care, and improve infrastructure like broadband access and patient devices. The program requires annual reports on outcomes after three years and every two years, with up to $10 million allocated yearly from 2025 through 2029. This initiative aims to address geographic and occupational barriers to mental health care access.
This bill prevents employers from dropping health insurance coverage for workers during strikes or lockouts. It amends the National Labor Relations Act to prohibit employers from terminating group health plan coverage for employees who are either locked out (during bargaining disputes) or participating in a lawful strike. Employers who violate this rule face civil penalties of up to $75,000 per violation for lockout-related actions (doubling to $150,000 for repeat offenses) or $50,000 for strike-related actions (doubling to $100,000 for repeat offenses). The law directly affects workers engaged in strikes or locked out by employers, ensuring their healthcare coverage continues during these labor disputes.
The POP Act (HR 5433) prohibits any entity from owning both a Medicare-focused health insurance company and certain healthcare providers (like clinics or outpatient facilities, excluding hospitals, pharmacies, and durable medical equipment suppliers). It requires violators to divest one business within 1-2 years of the law's enactment or acquisition. The Federal Trade Commission and state attorneys general can enforce this through civil actions, including ordering divestment and recovering revenue from violations. The law also updates Medicare rules to ban such ownership for Medicare Advantage plans starting in 2026, treating violations as false claims. This directly affects health insurers and provider networks operating under Medicare.
The End Price Gouging for Medications Act establishes annual reference prices for prescription drugs based on the lowest retail prices in 12 international reference countries (like Canada and the UK) or specific criteria if international data is unavailable. It requires drug manufacturers to sell medications at or below these reference prices for all patients covered by federal health programs - including Medicare, Medicaid, TRICARE, and VA care - as well as for all other patients, including those with private insurance. Manufacturers violating this rule face civil penalties of five times the revenue difference, with collected funds directed to the National Institutes of Health for drug research. This bill directly affects drug manufacturers and millions of Americans enrolled in the specified federal health programs.
This non-binding Senate resolution (SRES 389) condemns Secretary of Health and Human Services Robert F. Kennedy, Jr.'s actions dismissing the CDC's independent Advisory Committee on Immunization Practices and opposes Florida's 2025 policy rolling back school immunization requirements for children. It affirms that vaccines are critical for public health, preventable illness, and hospitalization reduction, and must be widely accessible at high community adoption rates. The resolution expresses the Senate's support for science-based vaccine policies, opposes politicizing medical recommendations, and emphasizes that vaccines should remain affordable and available through insurance and community settings like clinics and pharmacies. It does not create new laws but formally states the Senate's position against policies it views as endangering public health.
SRES 67 is a Senate resolution declaring racism a public health crisis in the United States. It cites documented racial health disparities - including lower life expectancy, higher maternal mortality, and disproportionate disease burdens among Black, American Indian, Alaska Native, and other minority communities - as meeting public health crisis criteria (affecting many, unfairly distributed, preventable, and lacking current solutions). The resolution calls for a nationwide strategy to dismantle systemic racism and address social determinants of health (like housing, education, and healthcare access), but it does not create new laws or funding. As a symbolic resolution, it aims to prompt government action rather than impose policy changes.
